Table 6.

Recommended Surveillance for Individuals with Myotonic Dystrophy Type 2

System/ConcernEvaluationFrequency
Neurology –
weakness & myotonia
Eval by neurologist, OT, & PTAnnually
Ophthalmology –
cataracts
Ophthalmology exam for posterior subcapsular cataracts & epiretinal membranes
Cardiac arrhythmia
& cardiomyopathy
  • EKG
  • Echocardiogram
  • 24-hr Holter monitoring
Consider cardiac MRI.Per cardiologist
Endocrine
  • Fasting serum glucose concentration
  • Glycosylated hemoglobin level
  • Thyroid hormone levels
  • Serum vitamin D
Annually
Serum testosterone & FSH concentrations in malesFrequency as per sign/symptoms of hypogonadism or per endocrinologist

OT = occupational therapist; PT = physical therapist

From: Myotonic Dystrophy Type 2

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.